Treatment of rheumatoid arthritis with oral type II collagen: Results of a multicenter, double-blind, placebo-controlled trial
โ Scribed by Martha L. Barnett; Joel M. Kremer; E. William St. Clair; Daniel O. Clegg; Daniel Furst; Michael Weisman; Malcolm J. F. Fletcher; Scott Chasan-Taber; Eduardo Finger; Alejandro Morales; Christine H. Le; David E. Trentham
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 892 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Objective Interleukinโ6 (ILโ6) is a pleiotropic cytokine that regulates the immune response, inflammation, and hematopoiesis. Overproduction of ILโ6 plays pathologic roles in rheumatoid arthritis (RA), and the blockade of ILโ6 may be therapeutically effective for the disease. This s
## Abstract ## Objective To determine whether patients with undifferentiated arthritis (UA; inflammatory, nontraumatic arthritis that cannot be diagnosed using current classification criteria) benefit from treatment with methotrexate (MTX). ## Methods The PRObable rheumatoid arthritis: Methotrex